U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Belzutifan (Welireg): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with von Hippel-Lindau disease who require therapy for associated nonmetastatic renal cell carcinoma, central nervous system hemangioblastomas, or nonmetastatic pancreatic neuroendocrine tumours, not requiring immediate surgery [Internet].

Belzutifan (Welireg): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with von Hippel-Lindau disease who require therapy for associated nonmetastatic renal cell carcinoma, central nervous system hemangioblastomas, or nonmetastatic pancreatic neuroendocrine tumours, not requiring immediate surgery [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Sep.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...